| Urinary Tract Neoplasm studied in …STUDIED_INderived200 of 2,186show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Bladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502095Phase 4 · completed Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04628767Phase 2/Phase 3 · recruiting Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05874921recruiting uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891171Phase 1 · active not recruiting Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524544Phase 3 · recruiting A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671092early Phase 1 · recruiting Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04235764recruiting En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04235777Phase 1 · active not recruiting Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05562830Phase 1/Phase 2 · recruiting A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A) · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06331299Phase 3 · active not recruiting A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06833073Phase 2 · recruiting A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06919965Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180212NA · active not recruiting Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07421700Phase 1/Phase 2 · recruiting Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07498907Phase 3 · recruiting Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00745355active not recruiting Quality of Life in Patients With Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03093922Phase 2 · completed A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04640623Phase 2 · active not recruiting A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04658862Phase 3 · active not recruiting A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316155Phase 1/Phase 2 · active not recruiting Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714202Phase 3 · active not recruiting A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06211764Phase 3 · active not recruiting A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319820Phase 3 · recruiting A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06877676approved for marketing Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309445recruiting A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419295Phase 3 · recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735793not yet recruiting A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290687Phase 2 · withdrawn Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217496Phase 1 · not yet recruiting N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07800507Phase 1/Phase 2 · not yet recruiting Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07837622Phase 2 · not yet recruiting A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04963153Phase 1 · active not recruiting Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06703476Phase 3 · recruiting A Study of Surgical Techniques During Cystectomy · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218380Phase 3 · recruiting A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835035Phase 1 · recruiting Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968732NA · active not recruiting Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04503577recruiting Prospective Bladder Cancer Infrastructure (ProBCI) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04506554Phase 2 · active not recruiting A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439836Phase 1 · recruiting Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06529822Phase 1 · recruiting Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638410NA · recruiting Prehabilitation in High-risk Oncologic Surgery · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07804056Phase 3 · recruiting A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829783Phase 3 · not yet recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer (MK-2870-055) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047693Phase 2 · terminated Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06227065Phase 2 · not yet recruiting Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06948552Phase 2 · recruiting Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827612Phase 2 · not yet recruiting A Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Urinary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704832NA · completed Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080998active not recruiting Longitudinal Bladder Cancer Study for Tumour Recurrence · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05239624Phase 2 · recruiting Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06394570Phase 1/Phase 2 · recruiting Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06733363Phase 2 · recruiting A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07043972Phase 2 · recruiting Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332351Phase 2 · not yet recruiting Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352962Phase 1 · completed Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Urethra Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579224Phase 3 · active not recruiting Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04940299Phase 2 · active not recruiting Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05464576NA · recruiting Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796375Phase 2 · recruiting Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05889195active not recruiting Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07532902Phase 1 · recruiting A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822373Phase 2 · not yet recruiting A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05494411available Named Patient Program for Mitomycin for Pyelocalyceal Solution · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538663Phase 3 · active not recruiting Intravesical BCG vs GEMDOCE in NMIBC · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07777848Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC). · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820566recruiting Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney, Bladder, and Prostate Cancers) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821177early Phase 1 · active not recruiting Bladder Preservation or Cystectomy for MIBC · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977453Phase 1/Phase 2 · recruiting GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05014139Phase 1 · terminated A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped PROBABILISTIC · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038928recruiting TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07643519Phase 2 · not yet recruiting Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817173NA · not yet recruiting Feasibility of HISA During TURBT for NMIBC · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06443944available An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990061NA · recruiting Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222488Phase 1/Phase 2 · recruiting A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566156Phase 3 · recruiting Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815665Phase 2/Phase 3 · recruiting A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03661320Phase 3 · completed A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06040762NA · recruiting A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06293898Phase 1 · recruiting Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416123Phase 1 · recruiting A Study of GEN1106 in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548476NA · recruiting Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365157Phase 1/Phase 2 · active not recruiting Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02675829Phase 2 · completed Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001823recruiting Evaluation for NCI Surgery Branch Clinical Research Protocols · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148765NA · active not recruiting Use of Wearables Following Cystectomy- Part II · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07189793Phase 2 · not yet recruiting Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807345Phase 1 · not yet recruiting Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465069Phase 1 · recruiting A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07144319recruiting Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463963NA · recruiting Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978118active not recruiting Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers) · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06337084Phase 1 · active not recruiting Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06567743Phase 2 · recruiting Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617169Phase 1 · active not recruiting Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06774131Phase 3 · recruiting A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07414992Phase 2 · withdrawn A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01261728Phase 2 · completed Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657486NA · completed BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03502785Phase 1/Phase 2 · completed INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04917809Phase 2 · active not recruiting A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05704244Phase 3 · active not recruiting Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05837767NA · recruiting A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864144Phase 1/Phase 2 · completed A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661720Phase 3 · recruiting Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06904365recruiting Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06972771recruiting Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185945Phase 2 · not yet recruiting Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07232602Phase 1/Phase 2 · recruiting KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793240not yet recruiting Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC) · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798479completed Age and Bladder Cancer Outcomes After BCG Treatment: A Multicenter Study · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02625961Phase 2 · terminated Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026884recruiting Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02379429recruiting Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244384Phase 3 · active not recruiting Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03473743Phase 1/Phase 2 · active not recruiting A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03775265Phase 3 · active not recruiting Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05567185Phase 1 · active not recruiting A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781852early Phase 1 · not yet recruiting Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07782164recruiting Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784387recruiting A Study to Characterize High-Risk Non-Muscle-Invasive Bladder Cancer Participants in Portugal · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793318Phase 2 · not yet recruiting TR115 in ARID1A-Mutated Advanced Solid Tumors · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793578Phase 1/Phase 2 · not yet recruiting Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06582017Phase 1 · recruiting Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07660055Phase 1 · recruiting Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789119not yet recruiting Prospective Collection And Molecular Analysis Of Biospecimens And Clinical Data From Patients With Urothelial Carcinoma And Related Malignancies Of The Urinary Tract · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180121enrolling by invitation Information Needs and Supportive Rehabilitation Over Time in Patients Undergoing Cystectomy in Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03258593Phase 1 · completed Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414317NA · active not recruiting An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07579195Phase 1/Phase 2 · recruiting Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783815Phase 1 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Intravesical Instillation of Disitamab Vedotin Combined With Toripalimab in Patients With HER2-Positive High-Risk Non-Muscle Invasive Bladder Cancer Who Are BCG-Naïve or Have BCG Failure · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00902590active not recruiting A Genotype-Phenotype Urothelial Cancer Registry · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Renal Pelvis Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03185468Phase 1/Phase 2 · terminated Intervention of Bladder Cancer by CAR-T · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781956NA · not yet recruiting Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579380Phase 2 · active not recruiting Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Urinary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06862219Phase 4 · recruiting A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07480356Phase 3 · recruiting Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623369Phase 1 · recruiting A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04410302recruiting Patient-Derived Xenografts to Reduce Cancer Health Disparities · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902872Phase 1/Phase 2 · completed Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05614739Phase 1 · recruiting FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3 · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07129993Phase 2/Phase 3 · recruiting Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227077NA · recruiting Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193970recruiting Measuring Surgical Recovery After Radical Cystectomy · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06059547Phase 2 · completed Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609269enrolling by invitation Decipher Genomics Resource for Intelligent Discovery · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966024Phase 1 · recruiting Study of DCC-2812 in Participants With Advanced Genitourinary Cancers · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895709Phase 1/Phase 2 · recruiting A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05776758Phase 3 · active not recruiting Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06011954recruiting A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762820NA · not yet recruiting REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05335941Phase 2 · active not recruiting A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187635NA · recruiting Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07726602recruiting Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07758881NA · not yet recruiting Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC. · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02769962Phase 1/Phase 2 · terminated Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03782207completed A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041503Phase 2 · recruiting Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Bladder Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07655284Phase 3 · withdrawn STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy · condition mapped PROBABILISTIC · 2,186 trials mapped (733 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762586Phase 2 · recruiting Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC) · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07763197recruiting Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05929235Phase 1 · active not recruiting A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma · condition mapped CURATED_BROADER · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Bladder Flat Urothelial Carcinoma In Situ | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04179162Phase 1/Phase 2 · active not recruiting Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment · condition mapped ALIAS · 2,186 trials mapped (733 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05706129Phase 1/Phase 2 · recruiting A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped CURATED_EXACT · 2,186 trials mapped (733 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412848completed JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study · condition mapped ONTOLOGY_EXACT · 2,186 trials mapped (733 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |